Clinical trials for Acquired cystic disease-associated renal cell carcinoma
100 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGN/ANCT06882486Post-immunotherapy Nephrectomy for Metastatic Kidney Cancer After Complete or Major Response to Systemic TherapyInstitut Paoli-Calmettes
- RECRUITINGPhase 1NCT07517198Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid TumorsExscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.
- RECRUITINGN/ANCT06907095Cohort Evaluation of Body Fluids Early Detection of Cancer in High-risk IndividualsGustave Roussy, Cancer Campus, Grand Paris · PI: Suzette Delaloge, MD
- RECRUITINGN/ANCT07461090Laparoscopic Versus Open Nephrectomy : Clinical Effectivness and Cost AnalysisMenoufia University
- RECRUITINGPhase 1NCT07195682A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)Bristol-Myers Squibb · PI: Bristol-Myers Squibb
- RECRUITINGPhase 1NCT07006688A Study of an IDH1m Inhibitor in Participants With IDH1-Mutated Malignancies and Hepatic or Renal ImpairmentServier Bio-Innovation LLC
- RECRUITINGPHASE1, PHASE2NCT07219576Retifanlimab and Ruxolitinib In Solid MalignanciesUniversity of California, San Diego · PI: Rana McKay
- RECRUITINGPHASE1, PHASE2NCT07239596Phase Ib/II Clinical Study of SHR-8068 Combined With Adebrelimab and Other Anti-tumor Drugs in the Treatment of Advanced Renal Cell CarcinomSuzhou Suncadia Biopharmaceuticals Co., Ltd.
- RECRUITINGNCT07299357Prospective Observational Trial of Image-guided Ablative STereotactic bOdy Radiation Therapy for Primary kidNey Cancer: the STONE TrialIstituto Clinico Humanitas
- RECRUITINGPhase 2NCT07223424Patient Preference for Subcutaneous vs. Intravenous Immune TherapyDiwakar Davar · PI: Diwakar J Davar, MD
- RECRUITINGN/ANCT07540260CAIX PET/ CT Guided Radiation Therapy in CcRCC.Peking University First Hospital
- RECRUITINGNCT07037589Women With isoLated acUte cyStitis and Macroscopic Hematuria. Is Further Investigation Needed?Vastra Gotaland Region · PI: Suleiman Abuhasanein
- RECRUITINGPhase 2NCT07072728Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment DisorderPsyence Australia Pty Ltd · PI: Clive Ward-Able
- RECRUITINGPhase 4NCT07028125Digital Monitoring of Self-reported Symptoms by Patients Treated With Cabozantinib Plus Nivolumab for Advanced Clear-cell Renal CarcinomaCentre Francois Baclesse
- RECRUITINGNCT06868927Targeted Decision Making In Renal Cell Carcinoma Relying on a Radiogenomics Translational PlatformIRCCS San Raffaele
- RECRUITINGNCT07294859Contrast-enhanced Ultrasound and Super-resolution Imaging Predict Renal Function Outcome After NephrectomyJinling Hospital, China
- ENROLLING BY INVITATIONNCT06885424A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) ProductsA2 Biotherapeutics Inc. · PI: Eric Ng, MD
- RECRUITINGPhase 1NCT07154901Investigation of the Effects of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of Opemalirsen (AZD2373)AstraZeneca
- RECRUITINGNCT07117227Development and Validation of RCC Predicting Model With Emulated-target TrialPeking University Third Hospital · PI: Yongyue Wei, master
- RECRUITINGNCT07118813Application of Radiomics-based AI Models in Predicting Clinical Outcome of Patients With Renal Cell Carcinoma After Surgical TreatmentUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology
- RECRUITINGPhase 2NCT07172386Preoperative Therapy of Super-selective Tumor Artery Embolization Combined With Toripalimab and Axitinib in Advanced RCCTianjin Medical University Second Hospital · PI: Changyi Quan, MD
- RECRUITINGPhase 2NCT06962787A Study of BL-B01D1+TKI±Pembrolizumab in Patients With Locally Advanced or Metastatic Renal CancerSichuan Baili Pharmaceutical Co., Ltd.
- RECRUITINGPhase 2NCT07386158Pucotenlimab Combination With Vorolanib as Neoadjuvant Therapy for ccRCCSun Yat-sen University
- ENROLLING BY INVITATIONPhase 2NCT0710190068Ga-NYM096 PET/ CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal MassesPeking Union Medical College Hospital
- ENROLLING BY INVITATIONN/ANCT07046832Clinical Evaluation of an Augmented Reality Intraprocedural Needle Guidance Platform for Soft Tissue BiopsyMediView XR, Inc.
- RECRUITINGEarly Phase 1NCT07067905Clinical Evaluation of [68Ga]Ga-XT771 PET for Diagnosis in Patients With Glioblastoma and Clear Cell Renal Cell CarcinomaChinese PLA General Hospital
- RECRUITINGNCT06955910Assessing Financial Toxicity Using the PROFFIT Questionnaire in Patients Treated With Mini-invasive Approach for Urological Malignancies.Istituto Oncologico Veneto IRCCS
- RECRUITINGPhase 4NCT06903312Primary Tumor Ablation and Outcome in Metastatic Renal Cell Carcinoma Treated With Immunotherapy Combinations.Fondazione Policlinico Universitario Agostino Gemelli IRCCS · PI: Roberto Iacovelli, M.D.; Ph.D.
- RECRUITINGN/ANCT07301827Study on the Diagnostic Value of Novel PET Molecular Imaging for Renal Cell CarcinomaUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology
- RECRUITINGN/ANCT07141225Application of the "Off-Clamp And Sutureless" Technique in Robot-Assisted Partial NephrectomyShao Pengfei · PI: Pengfei Shao, Professor
- RECRUITINGPHASE1, PHASE2NCT07053462CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection RiskAMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC
- RECRUITINGNCT06916624Multicenter Study of 18F-Labeled NY104 for PET/CT Imaging in Renal Cell CarcinomaThe Affiliated Hospital of Qingdao University
- ACTIVE NOT RECRUITINGNCT07101913Occurrence of Acute Kidney Injury After CAR-T Cells Treatments in B-cell Lymphoma.Hospices Civils de Lyon
- RECRUITINGNCT07024680Real World Study of Effectiveness of Sunitinib or Sorafenib to Chinese Unresectable Locally Advanced or Metastatic PRCCAstraZeneca · PI: DingWei Ye, Postdoctoral
- RECRUITINGPhase 2NCT06708949A Randomized Phase 2 Trial of Nivolumab, Relatlimab Plus Ipilimumab vs. Nivolumab Plus Ipilimumab in First-line Advanced Renal Cell Carcinoma (RCC)M.D. Anderson Cancer Center · PI: Eric Jonasch, MD
- RECRUITINGN/ANCT06525831Rein 3D PRINT MECHANICSUniversity Hospital, Bordeaux · PI: FOURAGE EVA, Dr
- RECRUITINGPhase 2NCT06376669Stereotactic Body Proton Therapy for Treatment of Primary Renal Cell CarcinomaSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · PI: Sherif Shaaban, MD
- RECRUITINGPhase 2NCT07175480PET/CT-Directed Free of Therapy for Metastatic RCC Patients With IMDC Favorable or Intermediate RiskJinling Hospital, China · PI: Le Qu
- RECRUITINGN/ANCT06745609Prehabilitation Prior to Surgery for Kidney TumorsHerlev and Gentofte Hospital
- RECRUITINGPhase 2NCT06730672An Exploratory Study on the Failure of Immunotherapy With Voronib Combined With EverolimusSun Yat-sen University · PI: Fangjian F Zhou, M.D
- RECRUITINGPHASE1, PHASE2NCT06432036Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE TrialJonsson Comprehensive Cancer Center · PI: Siddharth A Padia
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT06480565A Phase 1/2 Trial of ADI-270 in ccRCCAdicet Therapeutics
- RECRUITINGN/ANCT06908902Prospective Study on the Safety and Efficacy of Robot-Assisted Laparoscopic Partial Nephrectomy With Renal Artery Off-Clamp in the Treatment of cT1 Renal TumorsThe First Affiliated Hospital with Nanjing Medical University
- ACTIVE NOT RECRUITINGN/ANCT07173140Renal Tumour Imaging Using MRIUniversity College, London
- RECRUITINGNCT06886282Spatial RadiomIcs and TRanscriptomics to the DIscovery of the Cross-link Between Colon Cancer and ChrOnic Kidney DiseaseNational Cancer Institute, Naples
- RECRUITINGN/ANCT05810571Comparison of Postoperative Analgesic Efficacy of the Erector Spina Plane Block and Quadratus Lumborum Block in Open Nephrectomy: a Prospective Randomized Clinical StudyKocaeli University
- ACTIVE NOT RECRUITINGNCT06916910Analysis of Predictive Factors for Urinary Leakage After Partial Nephrectomy for Renal Hilum TumorsFirst Affiliated Hospital of Fujian Medical University
- RECRUITINGPhase 3NCT06726421Systemic Therapy Alone or With Stereotactic Body Radiotherapy for Oligometastatic Kidney Cancer (STROKER Study)Sun Yat-sen University
- RECRUITINGEarly Phase 1NCT06586658Anti-CD70-CAR-T Cell Injection for the Treatment of Locally Advanced or Relapsed/Metastatic CD70+ Inoperable Renal CellsShanghai Changzheng Hospital · PI: Shancheng Ren, MD,PhD
- ACTIVE NOT RECRUITINGPhase 2NCT06284564A Phase II Study Bolstering Outcomes by Optimizing Immunotherapy Strategies With Evolocumab and Nivolumab in Patients With Metastatic Renal Cell Carcinoma (BOOST-RCC)M.D. Anderson Cancer Center · PI: Eric Jonasch, MD
- RECRUITINGNCT06720532Kidney Function and Risk Factors in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Undergoing 177Lutetium-PSMA Radioligand Therapy: a Prospective Observational Study - KiRi-TrialHannah Schaefer
- RECRUITINGN/ANCT0651976068Ga-C1 PET/ CT Imaging in Clear Cell Renal Cell CarcinomaPeking University First Hospital · PI: Kan Gong
- RECRUITINGPhase 1NCT06399419CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney CancerOsel, Inc. · PI: Alex Chehrazi-Raffle, MD
- RECRUITINGNCT06548867Retrospective Analysis of Patients With Metastatic Renal Cell Carcinoma Treated With CABOzantinibGruppo Oncologico Italiano di Ricerca Clinica · PI: Carmine Pinto, MD
- RECRUITINGPhase 2NCT06265285Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) ProgramMayo Clinic · PI: Roxana S. Dronca, M.D.
- RECRUITINGPhase 3NCT06364631CARE1 Pragmatic Clinical TrialGustave Roussy, Cancer Campus, Grand Paris · PI: Laurence ALBIGES, MD, PhD
- RECRUITINGPhase 1NCT06259552A Study of SPX-303, a Bispecific Antibody Targeting LILRB2 and PD-L1 in Patients With Solid TumorsSparX Biotech(Jiangsu) Co., Ltd. · PI: Guidong Zhu
- RECRUITINGN/ANCT06278506Resection or Ablation of Small Kidney TumorsKarolinska University Hospital · PI: Anders Kjellman, MD, PhD
- RECRUITINGN/ANCT05410509"Embolization Before Ablation of Renal Cell Carcinoma (EMBARC)"University of Alabama at Birmingham · PI: Andrew Gunn, MD
- RECRUITINGNCT07395037A Study of Ward Admissions for HaematuriaBritish Urology Researchers in Surgical Training
- RECRUITINGPhase 2NCT06005818Molecular Residual Disease (MRD) Guided Adjuvant ThErapy in Renal Cell Carcinoma (RCC)University of Alabama at Birmingham · PI: Charles A Peyton, MD
- RECRUITINGPhase 2NCT05931393Sequential Treatment of Cabozantinib for Advanced Renal Cell Carcinoma (RCC)University of Texas Southwestern Medical Center · PI: Tian Zhang, MD
- RECRUITINGPhase 1NCT06010875A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid TumorsChongqing Precision Biotech Co., Ltd · PI: Fei Li, M.D
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT05808608A Study of AK104 Plus Axitinib in Advanced/Metastatic Special Pathological Subtypes of Renal Cell CarcinomaHao Zeng · PI: Hao Zeng, Professor
- RECRUITINGN/ANCT06101290Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER)University of California, Davis · PI: Mamta Parikh, MD, MS
- RECRUITINGPhase 2NCT05842044NSAID Use After Robotic Partial NephrectomyUniversity of Miami · PI: Mark L Gonzalgo, MD, PhD
- RECRUITINGNCT06076538PET/MR for Characterization of Renal Masses (RMs)University of Texas Southwestern Medical Center · PI: Ivan Pedrosa, MD, PhD
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT05864144A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid TumorsSensei Biotherapeutics, Inc. · PI: Ron Weitzman, MD
- RECRUITINGPhase 1NCT05868174Combination of 177Lu-TLX250 and Peposertib in Patients With Carbonic Anhydrase IX -Expressing Solid TumorsTelix Pharmaceuticals (Innovations) Pty Limited
- ACTIVE NOT RECRUITINGPhase 1NCT05789069A Study of HFB200603 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid TumorsHiFiBiO Therapeutics
- RECRUITINGPhase 3NCT05738694Neoadjuvant of Axitinib Plus PD-1 to Improve Disease Free Survival of Patients With Renal Cell CarcinomaZHOU FANGJIAN · PI: Fangjian Zhou, Professor
- RECRUITINGNCT05184790LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New TechnologyUniversity of Sydney · PI: Paul Keall
- RECRUITINGPhase 2NCT05327686Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI TrialNRG Oncology · PI: William A Hall
- RECRUITINGPhase 2NCT05361720Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC StudyVanderbilt-Ingram Cancer Center · PI: Brian I Rini, MD
- ACTIVE NOT RECRUITINGPHASE2, PHASE3NCT05522231Efficacy and Safety of Fruquintinib in Combination With Sintilimab in Advanced Renal Cell Carcinoma (FRUSICA-2)Hutchmed · PI: Dingwei Ye
- RECRUITINGPhase 1NCT05536141A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid TumorsArcus Biosciences, Inc. · PI: Medical Director
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT05620134Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic CancerSalubris Biotherapeutics Inc
- ACTIVE NOT RECRUITINGNCT05361434A Study of the Effectiveness of Cabozantinib in Combination With Nivolumab as First-line Treatment of Advanced Renal Cell Carcinoma (aRCC) in AdultsIpsen · PI: Ipsen Medical Director
- RECRUITINGPhase 2NCT05048212A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain MetastasesM.D. Anderson Cancer Center · PI: Jianbo Wang
- RECRUITINGNCT05318196Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related DiseasesUniversity Hospital, Toulouse · PI: Stanislas Faguer, MD, PhD
- RECRUITINGNCT06088134Contrast-enhanced CT-based Deep Learning Model for Preoperative Prediction of Disease-free Survival (DFS) in Localized Clear Cell Renal Cell Carcinoma (ccRCC)Mingzhao Xiao
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT05468697A Study of Belzutifan (MK-6482) in Combination With Palbociclib Versus Belzutifan Monotherapy in Participants With Advanced Renal Cell Carcinoma (MK-6482-024/LITESPARK-024)Merck Sharp & Dohme LLC · PI: Medical Director
- RECRUITINGPhase 1NCT05518253A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid TumorsWeijia Fang, MD · PI: Weijia Fang, M.D
- ACTIVE NOT RECRUITINGNCT04919122Outcomes Database to prospectivelY aSSEss the Changing TherapY Landscape in Renal Cell CarcinomaDuke University · PI: Daniel George, MD
- RECRUITINGNCT05287464International Multicentric Study ARON-1Hospital of Macerata
- RECRUITINGNCT05363657International REgistry of COnservative or Radical Treatment of Localized Kidney TumorsAzienda Ospedaliero-Universitaria Careggi · PI: Andrea Minervini, Prof.
- RECRUITINGPHASE1, PHASE2NCT05024214Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors3D Medicines (Sichuan) Co., Ltd. · PI: Tianshu Liu
- ACTIVE NOT RECRUITINGPhase 2NCT04953104ARID1A and/or KDM6A Mutation and CXCL13 ExpressionM.D. Anderson Cancer Center · PI: Sangeeta Goswami
- ACTIVE NOT RECRUITINGPhase 2NCT04387500Sintilimab Injection Combined With Inlyta in Fumarate Hydratase- Deficient Renal Cell CarcinomaWest China Hospital · PI: Hao Zeng
- RECRUITINGNCT05248412The Long-term Spill-over Impact of COVID-19 on Health and Healthcare of People With Non-communicable DiseasesThe University of Hong Kong · PI: Cindy L.K. Lam, MD
- ACTIVE NOT RECRUITINGPhase 1NCT04846920A Study of Belzutifan (MK-6482) in Participants With Advanced Clear Cell Renal Cell Carcinoma (MK-6482-018)Merck Sharp & Dohme LLC · PI: Medical Director
- RECRUITINGN/ANCT0498708668Ga-PSMA PET in the Renal Cell CarcinomaXijing Hospital
- RECRUITINGN/ANCT04605146Impact of Telemonitoring for the Management of Side Effects in Patients with Melanoma, Lung or Renal Cancer, Treated with Immunotherapy Combination of Nivolumab and Ipilimumab or Adjuvant Nivolumab MonotherapyHospices Civils de Lyon · PI: Stéphane DALLE
- RECRUITINGPhase 3NCT04510597Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE TrialSWOG Cancer Research Network
- ACTIVE NOT RECRUITINGNCT04761107Impact of COVID-19 on GU DiseaseIcahn School of Medicine at Mount Sinai · PI: Ashutosh K Tewari, MD
- RECRUITINGNCT04712305Urine Omics Predicting IO Therapy Responses in mRCC PatientsNational Taiwan University Hospital
- RECRUITINGNCT04681690German National Registry for NSSAssociation of Urologic Oncology (AUO) · PI: Nina Harke, Dr.
- ACTIVE NOT RECRUITINGPhase 2NCT04413123Cabozantinib In Combo With NIVO + IPI In Advanced NCCRCCBradley A. McGregor, MD · PI: Bradley McGregor, MD
- ACTIVE NOT RECRUITINGN/ANCT04503148Anesthesia and Cancer Study: Renal Cell CarcinomaSeoul National University Hospital
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT04140526Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLCOncoC4, Inc. · PI: Tianhong Li, MD